Breast Cancer

Breast cancer is one of the most common cancers globally, often driven by therapy resistance and metastasis. ALDH1A3 has been identified as a critical factor in promoting cancer stem cell survival, tumor progression, and metabolic adaptation, making it a key therapeutic target for improving outcomes in aggressive and recurrent breast cancers.